Clinical trial
5-AminoLevulinic Acid Aided Resection Margins in Sarcoma (5-ALARMS)
NCT07038278 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma (5-ALARMS)
- Lead sponsor
- University of Colorado, Denver
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- November 1, 2028
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
soft tissue sarcoma (sts)